SGS receives regulatory approval to restart human ¹⁴C ADME trials

Announcement reinforces SGS’s position as one of the few European CROs offering end-to-end human ADME programs.

About the Author

has written 21716 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com